LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Legal & Regulatory and Reimbursement/AAOS Guide to Manage Alternate Payment Risks
Legal & Regulatory and Reimbursement

AAOS Guide to Manage Alternate Payment Risks

February 3, 2021 2 min read Premium comments

Advertisement

AAOS Guide to Manage Alternate Payment Risks
Courtesy of American Academy of Orthopedic Surgeons
Secondary#americamacademyoforthopaedicsurgeons#orthopedicpractices#valuebasedpayment

The American Academy of Orthopaedic Surgeons (AAOS) wants to help you understand and successfully navigate the growing value-based payment landscape. To that end, the organization has developed an 18-page value-based care continuum (VBCC) guide to help your practice evaluate the various alternate payment models (APM) created by payers to achieve value-based care.

Click here for the guide.

The guide notes that providers who rely on fee-for-service and other retrospective payments during the COVID-19 pandemic, “are experiencing significant financial strain, since payment is made following the delivery of a specific service, vs. upfront management of a patient population.” A mix of prospective and retrospective payment sources “buffers a practice against the risk of a sudden rise or drop in utilization and creates more stability for practice finances.”

The Academy hopes the guide will help you identify where your practice’s existing payment arrangements fall along the continuum, understand the transition sought by payers to value-based care, and plan for continued changes in APM contracting arrangements.

In short, the guide helps you identify your risks and opportunities.

The typical assessment of an APM along the continuum, states the guide, “is the level of risk and opportunity that is involved for providers. The greater the opportunity for both financial gains and losses, typically the further along the continuum a given APM is found.”

Defining Cost, Quality and Value

Defining cost, quality and value is the key to finding your practice’s place along the continuum. So, the guide starts with clearing up confusion as various stakeholders have different definitions for the same terms used in a clinical setting.

Advertisement

The guide creates a “universal lens for interpreting this landscape. With the recent COVID pandemic, newer models that incorporate prospective (payment in advance of a service) may better insulate practices for the future.”

For example, here is how the Academy outlines a clear definition of cost, quality and value:

Quality

  • Is the successful delivery of appropriate, evidence-based musculoskeletal health care in an effort to achieve sustained patient-centered improvements in health outcomes and quality of life
  • Is exemplified by a physician-led musculoskeletal team focused on the individual patient’s preference in the delivery of care that is safe, accessible, equitable, and timely
  • Fosters evidence-based innovations essential for the advancement of professional and scientific knowledge.

Value

  • The relationship of a patient-centered health outcome to the total cost required to reach that outcome, given that care is:
  • evidence-based
  • appropriate
  • timely
  • sustainable
  • occurs throughout a full cycle of musculoskeletal care for a patient’s condition.

Cost

  • An investment and includes consideration of greater lifestyle and economic impacts.

Controlling Risk

Finally, knowing what risks are controllable can increase your likelihood of success before engaging an APM. Based on the size and scope of your practice, certain types of risk are more controllable than others. The AAOS strongly recommends that providers “focus on performance risk where they can have the most control and greatest impact.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy